article thumbnail

Vaccine Uptake Strategies & Ethical Considerations- Part II

Integrated Care News by CFHA

Vaccine hesitancy is the delay in accepting or refusing vaccination despite the availability of vaccination services. It falls on a spectrum of vaccine attitudes and intentions, from those who recognize the importance of vaccines and accept all vaccines on one end of the spectrum to those who refuse all vaccines.

article thumbnail

Many Older People Embrace Vaccines. Research Is Proving Them Right.

Physician's Weekly

Kim Beckham, an insurance agent in Victoria, Texas, had seen friends suffer so badly from shingles that she wanted to receive the first approved shingles vaccine as soon as it became available, even if she had to pay for it out-of-pocket. Some older people are really eager to be vaccinated. Kennedy Jr.,

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

HPV Vaccine Secondary Acceptance: Turning No into a Yes! [Child and adolescent health]

Annals of Family Medicine

Context: The human papillomavirus (HPV) vaccine is recommended starting at age 9 to reduce risk of HPV linked squamous cell cancers, yet recent data shows that only 58.6% have been vaccinated by age 17. Secondary acceptance is agreeing to a vaccine subsequent to declining in a previous encounter.

article thumbnail

Human papillomavirus vaccination in community-based clinics among adolescents by ethnicity, country of birth, and sex [Screening, prevention, and health promotion]

Annals of Family Medicine

HPV vaccination is recommended for all children starting at age nine years, and it is most effective before HPV exposure. Some research has found lower HPV vaccine uptake in Latino patients and others have demonstrated higher uptake by Latino subgroups. Dataset OCHIN electronic health record data from 27 US states.

article thumbnail

Texas invests $50M in psychedelic drug research to treat addiction

Medical Xpress

The goal is to support clinical trials and bring in another $50 million in private investment to help ibogaine win approval from the U.S. Other states like Oregon and Colorado have already launched legal clinics using psilocybin, the compound found in mushrooms, The Times reported. Food and Drug Administration (FDA).

article thumbnail

Rewiring the body clock: Deep brain imaging reveals unexpected complexity in jet lag adjustment

Medical Xpress

Consider supporting Science Xs mission by getting a premium account.

Provider 109
article thumbnail

Preemies receive sucrose for pain relief—new research shows it doesn't stop long-term impacts on development

Medical Xpress

Long-term effects of pain in early life We collected data on the number of procedures, clinical exposures and sucrose doses from three NICUs across Canada. But as the findings from our Canadian study show, we urgently need research to improve long-term health outcomes for children born prematurely.

IT 53